灌装製造市场规模、份额、成长分析（按产品类型、按药品类型、按最终用户、按地区）- 产业预测 2025-2032

2023 年灌装製造市场规模价值 167 亿美元，预计将从 2024 年的 182.7 亿美元成长到 2032 年的 374.9 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.4%。

截至 2023 年 10 月，全球对抗 COVID-19 的斗争正在激发製药和生物技术领域的活力，重点是疫苗开发和药物输送系统。目前，该产业有超过 155 种化合物和约 115 种候选疫苗处于研发阶段，并有望显着成长。对羟氯喹等成熟疗法的需求激增，凸显了对有效的 COVID-19 管理解决方案的迫切需求，并为製造商创造了有利可图的机会，特别是在面临供不应求的富裕市场。目前，最终产品製造中的先进技术正在满足日益增长的消费者需求并推动生物製药的发展。此外，用于肠外给药的预填充式注射器的日益普及预计将增强市场动态，并加强未来几年该行业的强劲发展轨迹。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 原料分析

灌装製造市场规模（按产品类型和复合年增长率） (2025-2032)

• 市场概览
• 耗材
  • 预填充式注射器
  • 管瓶
  • 管瓶
  • 塑胶管瓶
  • 墨水匣
  • 安瓿
  • 瓶塞和密封件
  • 管瓶瓶塞
  • 铝製箝口盖
  • 柱塞
  • 针
• 装置
  • 灌装机
  • 封口机
  • 检验机
  • 冷冻干燥设备
  • 贴标机
  • 旋盖机
  • 整合系统

灌装製造市场规模（依药品类型及复合年增长率）(2025-2032)

• 市场概览
• 生物製药
  • 单株抗体
  • 疫苗
  • 细胞和基因治疗
  • 重组蛋白
• 小分子
• 疫苗
• 其他注射剂

灌装製造市场规模（按最终用户和复合年增长率）(2025-2032)

• 市场概览
• 製药公司
• 生物製药公司
• 契约製造组织（CMO）

灌装製造市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific Inc.（USA）
• Cytiva（USA）
• Fujifilm Holdings Corporation（Japan）
• OPTIMA Packaging Group GmbH（Germany）
• Curia Global, Inc.（USA）
• Baxter International Inc.（USA）
• Becton, Dickinson and Company（USA）
• Aenova Group（Germany）
• SGD Pharma（France）
• Groninger & Co. GmbH（Germany）
• West Pharmaceutical Services, Inc.（USA）
• Stevanato Group（Italy）
• Syntegon Technology GmbH（Germany）
• Robert Bosch GmbH（Germany）
• Gerresheimer AG（Germany）
• Schott AG（Germany）
• IMA Group（Italy）
• AptarGroup, Inc.（USA）
• Nipro Corporation（Japan）
• Vetter Pharma-Fertigung GmbH & Co. KG（Germany）

结论和建议

Fill Finish Manufacturing Market size was valued at USD 16.7 billion in 2023 and is poised to grow from USD 18.27 billion in 2024 to USD 37.49 billion by 2032, growing at a CAGR of 9.4% during the forecast period (2025-2032).

As of October 2023, the global fight against COVID-19 continues to energize the pharmaceutical and biotechnology sectors, particularly in vaccine development and drug delivery systems. With over 155 drug compounds and approximately 115 vaccine candidates in research and development, the industry is poised for notable growth. A surge in demand for established treatments like hydroxychloroquine underscores the urgent need for effective COVID-19 management solutions, creating lucrative opportunities for manufacturers, especially in affluent markets facing supply shortages. Advanced technologies in fall-finish manufacturing now respond to escalating consumer needs, propelling biopharmaceutical growth. Additionally, the rising popularity of prefilled syringes for parenteral dosing is predicted to enhance market dynamics, reinforcing the industry's robust trajectory in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Fill Finish Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Fill Finish Manufacturing Market Segments Analysis

Global Fill Finish Manufacturing Market is segmented by Product Type, Drug Type, End-user and region. Based on Product Type, the market is segmented into Consumables and Equipment. Based on Drug Type, the market is segmented into Biologics, Small Molecules, Vaccines and Other Injectables. Based on End-user, the market is segmented into Pharmaceutical Companies, Biopharmaceutical Companies and Contract Manufacturing Organizations (CMOs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Fill Finish Manufacturing Market

The Fill Finish Manufacturing market is primarily driven by the increasing demand for biologics, including vaccines, monoclonal antibodies, and gene therapies. As the complexity of these biologics rises, ensuring their sterility throughout the filling and packaging processes becomes essential, leading to higher operational costs. Consequently, facilities are investing in advanced fill-finish technologies to meet the growing need for safe and efficient production of these critical drugs. This investment is vital for maintaining the integrity of biologics while satisfying market demand, ultimately propelling the growth of the Fill Finish Manufacturing sector.

Restraints in the Fill Finish Manufacturing Market

The global fill finish manufacturing sector is facing a significant challenge due to a shortage of skilled professionals who are proficient in operating advanced manufacturing technologies and software. This lack of expertise hampers the effective adoption of automation and other technological innovations, particularly in regions where the pharmaceutical industry is still emerging. As a result, the growth and modernization of the fill finish manufacturing market are hindered, limiting its potential to improve efficiency and productivity. Addressing this skills gap is crucial to unlock the full benefits of technological advancements in the industry and facilitate its development.

Market Trends of the Fill Finish Manufacturing Market

The fill-finish manufacturing market is currently experiencing a significant surge driven by the rising demand for biologics and biosimilars. As pharmaceutical companies strive to deliver innovative therapies, there is a notable shift towards enhancing production capabilities. This trend is prompting manufacturers to invest in advanced technologies and streamlined processes aimed at improving production efficiency, ensuring product quality, and adhering to stringent regulatory standards associated with these complex biologics. Additionally, the proliferation of personalized medicine is further propelling the need for specialized fill-finish services, thus transforming the competitive landscape and driving growth within the industry by facilitating faster and more reliable product delivery to meet market demands.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Raw Material Analysis

Global Fill Finish Manufacturing Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Consumables
  • Prefilled syringes
  • Vials
  • Glass Vials
  • Plastic Vials
  • Cartridges
  • Ampoules
  • Stoppers & Seals
  • Vial Stoppers
  • Aluminum Crimp Caps
  • Plungers
  • Needles
• Equipment
  • Filling Machines
  • Closing/Sealing Machines
  • Inspection Machines
  • Lyophilizers
  • Labeling Machines
  • Capping Machines
  • Integrated Systems

Global Fill Finish Manufacturing Market Size by Drug Type & CAGR (2025-2032)

• Market Overview
• Biologics
  • Monoclonal Antibodies
  • Vaccines
  • Cell & Gene Therapies
  • Recombinant Proteins
• Small Molecules
• Vaccines
• Other Injectables

Global Fill Finish Manufacturing Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Companies
• Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)

Global Fill Finish Manufacturing Market Size & CAGR (2025-2032)

• North America (Product Type, Drug Type, End-user)
  • US
  • Canada
• Europe (Product Type, Drug Type, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Drug Type, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Drug Type, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Drug Type, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OPTIMA Packaging Group GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curia Global, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aenova Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGD Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Groninger & Co. GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syntegon Technology GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Robert Bosch GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schott AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IMA Group (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetter Pharma-Fertigung GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations